Missed dose of anticoagulant management
Pro Research Analysisby 
Searched over 200M research papers
Missed Anticoagulant Dose Management: Clinical Risks and Remedial Strategies
Impact of Missed or Inappropriate Anticoagulant Dosing
Missing doses or taking lower-than-recommended doses of direct oral anticoagulants (DOACs) or non-vitamin K antagonist oral anticoagulants (NOACs) significantly increases the risk of adverse clinical outcomes. Studies show that patients who miss doses or are underdosed have a higher risk of major vessel occlusion and recurrent ischemic stroke, especially in those with atrial fibrillation (AF) or after percutaneous coronary intervention (PCI) 23. Meta-analyses confirm that inappropriately low DOAC dosing is linked to a higher rate of stroke or systemic embolism compared to standard dosing, without a significant reduction in major bleeding events . Additionally, nonrecommended dosing (both underdosing and overdosing) is associated with increased all-cause mortality, mainly due to cardiovascular causes .
Adherence and Its Clinical Relevance
Adherence to anticoagulant therapy is crucial. Even missing more than 5% of prescribed doses is associated with a significant increase in thromboembolic events . This is true for both DOACs and vitamin K antagonists (VKAs), though adherence tends to be slightly better with VKAs due to regular monitoring requirements . In pediatric and young adult populations, barriers to adherence are common, and missing doses is frequently reported, further emphasizing the need for strategies to support consistent medication use .
Remedial Dosing Approaches for Missed DOAC Doses
Traditional guidelines for managing missed DOAC doses are often generic and may not minimize the time patients spend outside the therapeutic window. Recent research supports a model-informed remedial approach, which uses patient-specific factors to recommend the best remedial dosing regimen. This approach has been shown to be superior to existing guidelines and is now available via web-based dashboards to assist clinicians in real-time decision-making .
Dosing Regimens and Monitoring
There is no significant difference in efficacy or safety between once-daily and twice-daily DOAC regimens, even in the context of missed doses, suggesting that regimen choice can be tailored to patient preference and likelihood of adherence . For NOACs, routine laboratory monitoring is not required due to their predictable pharmacological profiles, and fixed dosing remains the standard of care. However, patient-specific factors such as age and kidney function should be considered, as they can affect drug levels and outcomes .
Comprehensive Anticoagulant Management
Optimal management of anticoagulant therapy requires a knowledgeable provider, organized follow-up, and good patient education. Ensuring patients understand the importance of adherence and providing clear instructions for missed doses are key components of effective anticoagulant management .
Conclusion
Missing or underdosing anticoagulants increases the risk of stroke, systemic embolism, and mortality, especially in high-risk populations. Adherence is critical, and even a small proportion of missed doses can have significant clinical consequences. Model-informed remedial dosing strategies and patient education are essential tools to minimize risks associated with missed anticoagulant doses and to optimize patient outcomes 1234+2 MORE.
Sources and full results
Most relevant research papers on this topic